Cite
Serotonin and norepinephrine reuptake inhibitors antidepressant use is related to lower baroreflex sensitivity independently of the severity of depressive symptoms. A community-study of 9213 participants from the Paris Prospective Study III.
MLA
Empana, Jean-Philippe, et al. “Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Use Is Related to Lower Baroreflex Sensitivity Independently of the Severity of Depressive Symptoms. A Community-Study of 9213 Participants from the Paris Prospective Study III.” Atherosclerosis (00219150), vol. 251, Aug. 2016, pp. 55–62. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2016.05.040.
APA
Empana, J.-P., Prugger, C., Thomas, F., Perier, M.-C., Zanoli, L., Castiglioni, P., Guibout, C., Causeret, S., Barnes, C., Lemogne, C., Parati, G., Laurent, S., Pannier, B., Boutouyrie, P., & Jouven, X. (2016). Serotonin and norepinephrine reuptake inhibitors antidepressant use is related to lower baroreflex sensitivity independently of the severity of depressive symptoms. A community-study of 9213 participants from the Paris Prospective Study III. Atherosclerosis (00219150), 251, 55–62. https://doi.org/10.1016/j.atherosclerosis.2016.05.040
Chicago
Empana, Jean-Philippe, Christof Prugger, Frédérique Thomas, Marie-Cécile Perier, Luca Zanoli, Paolo Castiglioni, Catherine Guibout, et al. 2016. “Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Use Is Related to Lower Baroreflex Sensitivity Independently of the Severity of Depressive Symptoms. A Community-Study of 9213 Participants from the Paris Prospective Study III.” Atherosclerosis (00219150) 251 (August): 55–62. doi:10.1016/j.atherosclerosis.2016.05.040.